|
MUTED expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.112970E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.802200E-01 |
| Normal-vs-Stage2 |
1.743630E-01 |
| Normal-vs-Stage3 |
8.471800E-01 |
| Normal-vs-Stage4 |
8.939000E-01 |
| Stage1-vs-Stage2 |
5.602800E-01 |
| Stage1-vs-Stage3 |
6.704600E-01 |
| Stage1-vs-Stage4 |
7.771400E-01 |
| Stage2-vs-Stage3 |
3.758400E-01 |
| Stage2-vs-Stage4 |
4.489000E-01 |
| Stage3-vs-Stage4 |
9.951400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.481800E-02 |
| Normal-vs-AfricanAmerican |
9.639200E-01 |
| Normal-vs-Asian |
6.178200E-01 |
| Caucasian-vs-AfricanAmerican |
9.125800E-02 |
| Caucasian-vs-Asian |
3.538800E-01 |
| AfricanAmerican-vs-Asian |
5.087000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.730000E-01 |
| Normal-vs-Female |
5.843800E-02 |
| Male-vs-Female |
2.208000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.190600E-01 |
| Normal-vs-Extreme_Weight |
6.301800E-01 |
| Normal-vs-Obese |
5.086200E-02 |
| Normal-vs-Extreme_Obese |
6.334600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.435000E-01 |
| Normal_Weight-vs-Obese |
4.739600E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.380600E-01 |
| Extreme_Weight-vs-Obese |
2.119000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.853000E-01 |
| Obese-vs-Extreme_Obese |
7.111200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.688000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.655800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.104000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.473800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.877400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.011200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.615600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.081500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.661600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.670600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.720400E-03 |
| Normal-VS-Type2 PRCC |
7.351800E-01 |
| Normal-VS-KIRP CIMP |
4.760600E-01 |
| Normal-VS-Unclassified PRCC |
2.905600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.249790E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.203760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.976200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.585800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.026200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.978400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.002000E-01 |
| Normal-vs-N1 |
2.745200E-01 |
| Normal-vs-N2 |
4.795500E-03 |
| N0-vs-N1 |
1.370410E-01 |
| N0-vs-N2 |
1.443950E-01 |
| N1-vs-N2 |
1.575630E-03 |
|
|
